As we head into 2025, the pharmaceutical landscape is set to welcome some exciting new treatments. Before these therapies reach the market, each undergoes a rigorous FDA approval process designed to ensure safety, efficacy, and quality. For patients, caregivers, and healthcare professionals alike, these approvals represent potential shifts in managing complex conditions, from Alzheimer’s to rare cancers. Here are ten anticipated drug approvals that could shape the future of healthcare and provide much-needed options for patients:
Suzetrigine
Manufacturer: Vertex Pharmaceuticals
Indication: Acute pain management
Expected Approval Date: Early 2025
What Makes It Noteworthy: Non-opioid pain relief could reduce opioid dependency risks.
Zenocutuzumab
Manufacturer: Merus
Indication: NRG1 fusion-positive cancers
Expected Approval Date: February 2025
What Makes It Noteworthy: Gene-targeted therapy for rare cancer mutations.
Bkemv (Eculizumab)
Manufacturer: Amgen
Indication: Paroxysmal nocturnal hemoglobinuria (PNH)
Expected Approval Date: March 2025
What Makes It Noteworthy: Affordable biosimilar to Soliris.
Donanemab
Manufacturer: Lilly
Indication: Alzheimer’s disease
Expected Approval Date: Early 2025
What Makes It Noteworthy: Targets brain plaques, potentially slowing Alzheimer’s progression.
Tarlatamab
Manufacturer: Amgen
Indication: Small cell lung cancer
Expected Approval Date: Mid-2025
What Makes It Noteworthy: Novel antibody-based treatment for hard-to-treat lung cancer.
Mavorixafor
Manufacturer: X4 Pharmaceuticals
Indication: WHIM syndrome
Expected Approval Date: First half of 2025
What Makes It Noteworthy: First targeted treatment for this rare immune disorder.
Elafibranor
Manufacturer: Genfit
Indication: Primary biliary cholangitis
Expected Approval Date: Mid-2025
What Makes It Noteworthy: Offers relief for chronic liver disease, with fewer side effects.
Imetelstat
Manufacturer: Geron Corporation
Indication: Myelodysplastic syndromes
Expected Approval Date: Second half of 2025
What Makes It Noteworthy: New option for blood disorders that can lead to leukemia.
Tirzepatide
Manufacturer: Lilly
Indication: New indication obstructive sleep apnea
Expected Approval Date: Late 2025
What Makes It Noteworthy: New approach to sleep apnea, initially developed for diabetes.
Liraglutide
Looking Ahead: Why These Approvals Matter
The anticipated FDA approvals for 2025 signify a future where treatments are more targeted, accessible, and patient-centered. Yet for many patients, it’s not just about having more options—it’s about trusting what’s in them. Today’s consumers seek greater visibility into their medications, wanting to know that what they’re putting into their bodies aligns with their values.
This growing demand for transparency offers a chance for the pharmaceutical industry to lead with integrity and openness. By partnering with innovators like VeganMed, companies can foster trust and meet the evolving expectations of patients who value clear, honest communication about product ingredients. As these new treatments roll out, embracing transparency isn’t just good practice—it’s a meaningful step toward truly patient-focused care.
Co-authored by Reba Mathew
Disclaimer: The product and/or information provided on VeganMed is of a general nature and is not intended to be a substitute for professional medical advice, diagnosis, or treatment. We do not lab test the products to confirm that they are free from animal ingredients, and it is possible that the formulation and ingredients could have changed. Always seek the advice of your physician or other qualified healthcare provider with any questions you may have regarding a medical condition or product. The information provided in this post is accurate and up to date as of the date it was written. However, please note that circumstances and facts may change over time, and new information may become available that could alter the accuracy or relevance of the content. We encourage readers to verify and cross-reference any information provided here with trusted sources or consult relevant professionals for the most current and accurate updates.
Looking for certified and verified animal-free products?
Thank you for your awareness and concern for animal-derived ingredients!
As a reminder, please comment on our FDA Citizen Petition, requesting clear labeling of animal-derived ingredients in medications. Together, we can make a difference.
If you have any further questions about ingredients in your medicines and supplements, feel free to reach out to the VeganMed team!
Comments